Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00941460
What this trial is testing

Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Prof. Dr. Wolfgang Wick 105
Not applicableLooking for participantsNCT06661174
What this trial is testing

A Cohort Study on the Efficacy of Bariatric Surgery for Rapidly Progressing Diabetic Nephropathy

Who this might be right for
Bariatric SurgeriesDiabetic Nephropathy
China-Japan Friendship Hospital 100
Not applicableEnded earlyNCT04818580
What this trial is testing

Progressive Tension Sutures in Gender Affirming Mastectomy

Who this might be right for
HematomaSeroma
NYU Langone Health 3
Testing effectiveness (Phase 2)Study completedNCT01753713
What this trial is testing

Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
Manmeet Ahluwalia, MD 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06065670
What this trial is testing

Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy

Who this might be right for
Demyelinating DiseasesDemyelination; Corpus CallosumMultiple Sclerosis Brain Lesion+2 more
University of California, San Francisco 44
Large-scale testing (Phase 3)Study completedNCT01524783
What this trial is testing

Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin)

Who this might be right for
Advanced NET of GI OriginAdvanced NET of Lung OriginNeuroendocrine Tumors
Novartis Pharmaceuticals 302
Testing effectiveness (Phase 2)Looking for participantsNCT03109288
What this trial is testing

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

Who this might be right for
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 250
Not applicableStudy completedNCT06407869
What this trial is testing

Effects of Functional Progressive Strength Training in Children With Spastic Cerebral Palsy

Who this might be right for
Spastic Cerebral Palsy
Riphah International University 40
Large-scale testing (Phase 3)Study completedNCT02873559
What this trial is testing

Effect of PROGRESSive Training and Teststerone in Older Frail Men

Who this might be right for
Muscle Weakness
University Hospital, Gentofte, Copenhagen 192
Not applicableEnded earlyNCT02445469
What this trial is testing

Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Syndromes

Who this might be right for
Parkinson's DiseaseMultiple System AtrophyProgressive Supranuclear Palsy+1 more
University Hospital, Montpellier 130
Testing effectiveness (Phase 2)Study completedNCT00003241
What this trial is testing

Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Texas Children's Cancer Center
Not applicableEnded earlyNCT01230879
What this trial is testing

Effect of Ageing on Airway Remodeling

Who this might be right for
Aging
University Hospital, Montpellier 101
Large-scale testing (Phase 3)UnknownNCT00815256
What this trial is testing

Safety and Effectiveness of Collagen Cross Linking in Progressive Mild and Moderate Keratoconus

Who this might be right for
Cornea DegenerationProgressive Keratoconus
Federal University of São Paulo 15
Not applicableLooking for participantsNCT06103669
What this trial is testing

Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)

Who this might be right for
Breast CancerOligoprogressiveHead and Neck Cancer+2 more
University of California, Davis 250
Early research (Phase 1)Study completedNCT02506751
What this trial is testing

Open-label Study of Liothyronine in MS

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary Progressive
Johns Hopkins University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06801730
What this trial is testing

Irinotecan Liposomes Combined With Bevacizumab in the Treatment of Recurrent Glioma

Who this might be right for
Glioma
Zhifeng Tian,MD 38
Early research (Phase 1)Study completedNCT04023669
What this trial is testing

Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors

Who this might be right for
Brain TumorBrain Tumor, RecurrentBrain Tumor, Refractory+10 more
St. Jude Children's Research Hospital 21
Not applicableStudy completedNCT03399981
What this trial is testing

Tysabri Observational Cohort Study - Multiple Sclerosis (MS) Registries

Who this might be right for
Progressive Multifocal Leukoencephalopathy
Biogen 80,327
Not applicableAvailableNCT06802328
What this trial is testing

Intermediate-Size Patient Population Expanded Access: Foralumab in Non-Active Secondary Progressive MS Patients

Who this might be right for
Non-Active Secondary Progressive Multiple Sclerosis
Tiziana Life Sciences LTD
Testing effectiveness (Phase 2)Ended earlyNCT04006119
What this trial is testing

Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma

Who this might be right for
Glioblastoma
Alaunos Therapeutics 40
Next Page